# Cone-Beam CT in Interventional Radiology

## Introduction

**Cone-beam computed tomography (CBCT)** is an advanced imaging capability integrated into modern angiographic systems that provides three-dimensional, cross-sectional imaging during interventional procedures. By performing a rotational acquisition with the C-arm, CBCT bridges the gap between fluoroscopic guidance and conventional CT, enabling real-time volumetric assessment without transferring the patient.

## Physics and Image Acquisition

### Principles of CBCT

A **cone-shaped X-ray beam** and flat-panel detector rotate around the patient, typically through a 200-degree arc. Multiple projection images (150-600 frames) are acquired during the rotation over 5-20 seconds. Volumetric data is reconstructed using a **Feldkamp-Davis-Kress (FDK)** filtered back-projection algorithm. Spatial resolution approaches 0.1-0.2 mm, superior to multidetector CT for high-contrast structures.

### Acquisition Protocols

| Protocol | Contrast | Acquisition | Primary Application |
|----------|---------|-------------|-------------------|
| Non-contrast CBCT | None | Single rotation | Device position, lipiodol retention, bony anatomy |
| Contrast-enhanced CBCT | Selective arterial injection | Delayed rotation | Tumor vascularity, feeder identification |
| Dual-phase CBCT | Selective injection | Arterial + delayed | Tumor vs. parenchyma differentiation |

**Non-contrast CBCT**: assessment of device position, bony anatomy, or dense materials (e.g., lipiodol retention). **Contrast-enhanced CBCT**: selective arterial injection with delayed rotational acquisition to map tumor vascularity and perfusion. **Dual-phase CBCT**: arterial and delayed acquisitions to differentiate tumor enhancement from surrounding parenchyma.

![CBCT acquisition showing the C-arm rotation arc around the patient with cone-beam geometry](cbct-acquisition-geometry.png)

### Image Quality Considerations

**Cone-beam artifacts**: scatter, beam hardening, and truncation artifacts are more pronounced than in conventional CT. Motion artifacts from respiration can degrade image quality; breath-hold or respiratory gating is essential. **Soft tissue contrast** is inferior to multidetector CT due to increased scatter and limited dynamic range. Metal artifacts from coils, stents, or dense embolic material can obscure adjacent structures.

## Clinical Applications

### Hepatic Interventions

**Transarterial chemoembolization (TACE)**: CBCT identifies feeding arteries to hepatocellular carcinoma and confirms completeness of lipiodol deposition. **Radioembolization (Y-90)**: CBCT during mapping angiography verifies catheter position and detects extrahepatic perfusion. Intraprocedural CBCT changes management in up to **30%** of TACE cases by identifying additional tumors or feeders not seen on DSA.

### Percutaneous Procedures

**Needle guidance**: CBCT provides real-time confirmation of needle trajectory for biopsies, ablations, and drainages. Overlay of CBCT datasets onto live fluoroscopy creates **3D roadmaps** for navigating complex anatomy. Particularly valuable for lesions not visible on fluoroscopy or ultrasound.

### Vascular Interventions

Assessment of **stent deployment** and apposition in aortic endografts. Identification of **endoleak** sources following endovascular aneurysm repair. Evaluation of intracranial stent placement and coil packing in neurointerventional procedures.

![Intraprocedural CBCT during TACE showing tumor enhancement and catheter position in a hepatic artery branch](cbct-tace-procedure.png)

### Musculoskeletal Applications

**Vertebroplasty/kyphoplasty**: CBCT confirms cement distribution and detects early cement leakage. Assessment of screw placement in minimally invasive spine procedures. Guidance for sacroiliac joint and facet injections in challenging anatomy.

## Dose Considerations

A single CBCT acquisition delivers approximately **3-10 mGy** to the skin, comparable to 1-3 minutes of fluoroscopy. Cumulative dose increases significantly when multiple CBCT runs are performed. Dose reduction strategies include: Reducing number of projection images per rotation. Lowering mA and kVp settings when high-contrast structures are the target. Limiting the number of CBCT acquisitions to those that will change management.

## Integration with Navigation Systems

CBCT datasets can be fused with preprocedural **CT**, **MRI**, or **PET-CT** for multimodality guidance. **Electromagnetic navigation** systems use CBCT-derived 3D maps for catheter tracking without continuous fluoroscopy. Augmented fluoroscopy overlays CBCT-derived vascular maps onto live imaging, reducing contrast and radiation exposure.

![Fusion of preprocedural MRI with intraprocedural CBCT showing overlay guidance for hepatic tumor ablation](cbct-mri-fusion.png)

## Limitations

Limited **field of view** compared to conventional CT (typically 25 cm or smaller). Longer acquisition time increases susceptibility to **motion artifact**. Inferior soft tissue contrast compared to multidetector CT. Requires a trained operator to optimize acquisition parameters and interpret volumetric data. Not a substitute for diagnostic CT in most clinical scenarios.

## Key Clinical Pearls

CBCT during TACE can detect additional tumors missed on preprocedural imaging and DSA, changing treatment strategy in a significant proportion of cases. For Y-90 radioembolization, CBCT is essential for confirming catheter position and detecting non-target perfusion that could result in radiation injury to the lungs or GI tract. Breath-hold technique is critical for hepatic CBCT; even small respiratory motion degrades image quality and reduces diagnostic accuracy. When using CBCT for needle guidance, a single acquisition with 3D overlay can replace multiple fluoroscopic spot checks, potentially reducing overall dose.

## References

1. Tacher V, Radaelli A, Lin M, Geschwind JF. How I Do It: Cone-Beam CT during Transarterial Chemoembolization for Liver Cancer. Radiology. 2015;274(2):320-334.
2. Wallace MJ, Kuo MD, Glaiberman C, et al. Three-Dimensional C-Arm Cone-Beam CT: Applications in the Interventional Suite. J Vasc Interv Radiol. 2009;20(7 Suppl):S523-S537.
3. Orth RC, Wallace MJ, Kuo MD. C-Arm Cone-Beam CT: General Principles and Technical Considerations for Use in Interventional Radiology. J Vasc Interv Radiol. 2008;19(6):814-820.
4. Meyer BC, Frericks BB, Voges M, et al. Visualization of Hypervascular Liver Lesions During TACE: Comparison of Angiographic C-Arm CT and MDCT. AJR Am J Roentgenol. 2008;190(4):W263-W269.